News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
75,699 Results
Type
Article (966)
Company Profile (11)
Press Release (74722)
Section
Business (21247)
Career Advice (129)
Deals (8320)
Drug Development (6711)
Employer Resources (2)
FDA (1323)
Job Trends (1561)
News (38121)
Policy (2764)
Tag
Academia (88)
Allergies (2)
Alliances (5922)
ALS (8)
Alzheimer's disease (138)
Antibody-drug conjugate (ADC) (3)
Approvals (1336)
Artificial intelligence (6)
Automation (2)
Bankruptcy (84)
Best Places to Work (1392)
Biosimilars (9)
Biotechnology (7)
Bladder cancer (6)
Brain cancer (2)
Breast cancer (21)
Cancer (212)
Cardiovascular disease (7)
Career advice (110)
CAR-T (8)
Cell therapy (29)
Cervical cancer (1)
Clinical research (5696)
Collaboration (59)
Compensation (25)
COVID-19 (92)
C-suite (23)
Cystic fibrosis (10)
Data (218)
Depression (3)
Diabetes (20)
Diagnostics (690)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (2)
Duchenne muscular dystrophy (3)
Earnings (7478)
Employer branding (1)
Employer resources (2)
Events (10361)
Executive appointments (99)
FDA (1447)
Frontotemporal dementia (1)
Funding (85)
Gene editing (3)
Gene therapy (8)
GLP-1 (23)
Government (192)
Guidances (7)
Healthcare (1995)
Immunology and inflammation (4)
Indications (2)
Infectious disease (102)
Inflammatory bowel disease (17)
Influenza (5)
Intellectual property (11)
Interviews (23)
IPO (4857)
Job creations (208)
Job search strategy (93)
Layoffs (8)
Legal (900)
Liver cancer (3)
Lung cancer (35)
Lymphoma (10)
Manufacturing (18)
MASH (6)
Medical device (1817)
Medtech (1817)
Mergers & acquisitions (3727)
Metabolic disorders (42)
Multiple sclerosis (6)
NASH (1)
Neurodegenerative disease (2)
Neuroscience (186)
NextGen: Class of 2025 (905)
Non-profit (163)
Obesity (17)
Opinion (2)
Ovarian cancer (8)
Pain (11)
Pancreatic cancer (18)
Parkinson's disease (20)
Partnered (3)
Patents (36)
Patient recruitment (12)
Peanut (2)
People (6572)
Pharmacy benefit managers (1)
Phase I (1764)
Phase II (2642)
Phase III (1861)
Pipeline (146)
Policy (1)
Postmarket research (146)
Preclinical (687)
Press Release (1)
Prostate cancer (7)
Psychedelics (1)
Radiopharmaceuticals (44)
Rare diseases (27)
Real estate (525)
Recruiting (1)
Regulatory (1846)
Reports (5)
Research institute (136)
Resumes & cover letters (15)
RSV (3)
Schizophrenia (10)
Series A (7)
Series B (7)
Sickle cell disease (8)
Spinal muscular atrophy (2)
Startups (496)
State (1)
Stomach cancer (1)
Supply chain (8)
Vaccines (24)
Weight loss (2)
Date
Today (19)
Last 7 days (85)
Last 30 days (261)
Last 365 days (3911)
2025 (1185)
2024 (4447)
2023 (5501)
2022 (6720)
2021 (7851)
2020 (7552)
2019 (5271)
2018 (4083)
2017 (3918)
2016 (3233)
2015 (4529)
2014 (3094)
2013 (2533)
2012 (2710)
2011 (2362)
2010 (2113)
Location
Africa (20)
Alabama (2)
Arizona (23)
Arkansas (1)
Asia (3706)
Australia (469)
California (729)
Canada (152)
China (30)
Colorado (21)
Connecticut (46)
Delaware (12)
Europe (5225)
Florida (149)
Georgia (24)
Idaho (7)
Illinois (59)
India (1)
Indiana (55)
Japan (11)
Kansas (19)
Kentucky (2)
Maine (35)
Maryland (101)
Massachusetts (464)
Michigan (62)
Minnesota (43)
Mississippi (2)
Missouri (11)
Montana (2)
Nebraska (3)
Nevada (25)
New Hampshire (10)
New Jersey (271)
New Mexico (2)
New York (288)
North Carolina (187)
Northern California (260)
Ohio (31)
Oregon (2)
Pennsylvania (201)
Rhode Island (3)
South America (64)
South Carolina (6)
Southern California (300)
Tennessee (23)
Texas (170)
United States (3124)
Utah (41)
Virginia (27)
Washington D.C. (1)
Washington State (56)
West Virginia (1)
Wisconsin (11)
75,699 Results for "stimlabs llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Stimlabs(R) LLC Granted Issuance of Two New Patents Further Establishing the Company’s Intellectual Property Position for Advancements in Regenerative Medicine
Stimlabs LLC, a leader in regenerative medicine, continues to achieve advancements in the development and patenting of innovative, industry-leading technologies and products.
November 1, 2023
·
2 min read
Stimlabs® LLC Announces Launch of Relese® - A Uniquely Fenestrated Allograft for Chronic and Acute Wounds
Stimlabs LLC, (“StimLabs”), a leader in regenerative medicine, announced the launch of Relese, a fenestrated dehydrated complete human placental membrane (dCHPM) allograft for chronic and acute wounds.
August 24, 2023
·
2 min read
Press Releases
StimLabs Announces National Availability of Corplex P
October 2, 2024
·
4 min read
StimLabs® Announces IRB Approval for CAMPSTIM: The Largest Prospective Placental Tissue Allograft Trial for Diabetic Foot Ulcers
StimLabs, a leading regenerative medicine company, announced Institutional Review Board (IRB) authorization to begin the CAMPSTIM clinical trial, a multi-center randomized controlled trial to demonstrate the real-world benefits of StimLabs’ placental-based tissue products in treating patients with hard-to-heal diabetic foot ulcers (DFUs).
June 4, 2024
·
5 min read
Press Releases
StimLabs® Announces Exclusive Distribution Rights for Geistlich’s Leading Wound Care Portfolio
November 26, 2024
·
3 min read
Press Releases
Innovative Lab Services LLC Acquires Compco Analytical, Inc.
May 1, 2025
·
1 min read
Press Releases
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711
April 22, 2025
·
2 min read
Press Releases
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 - April 25, 2025
April 28, 2025
·
3 min read
Press Releases
Allakos Inc. Enters into Agreement to Be Acquired by Concentra Biosciences, LLC for $0.33 in Cash per Share
April 3, 2025
·
4 min read
Press Releases
Innovative Lab Services LLC Acquires PL Consultants, LLC to Expand Scientific Capabilities and Service Offerings
January 15, 2025
·
2 min read
1 of 7,570
Next
